Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1172 ARTÍCULOS , VIENDO DEL 376 AL 390

Alzheimer's disease: emerging trends in small molecule therapies

Mohamed T, Rao PP.

Curr Med Chem. 2011;18(28):4299-320. doi: 10.2174/092986711797200435.

Alzheimer's disease: clinical trials and the amyloid hypothesis

Cummings J.

Ann Acad Med Singap. 2011 Jul;40(7):304-6.

Role of serotonin in Alzheimer's disease: a new therapeutic target?

Geldenhuys WJ, Van der Schyf CJ.

CNS Drugs. 2011 Sep 1;25(9):765-81. doi: 10.2165/11590190-000000000-00000.

Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics

Mao P, Reddy PH.

Biochim Biophys Acta. 2011 Nov;1812(11):1359-70. doi: 10.1016/j.bbadis.2011.08.005. Epub 2011 Aug 18.

Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease

Reddy PH.

Brain Res. 2011 Sep 30;1415:136-48. doi: 10.1016/j.brainres.2011.07.052. Epub 2011 Jul 31.

Age-related loss of calcium buffering and selective neuronal vulnerability in Alzheimer's disease

Riascos D, de Leon D, Baker-Nigh A, Nicholas A, Yukhananov R, Bu J, Wu CK, Geula C.

Acta Neuropathol. 2011 Nov;122(5):565-76. doi: 10.1007/s00401-011-0865-4. Epub 2011 Aug 27.

[Cytoskeletal alterations in Alzheimer's disease: the "skeleton" of therapeutic hope?]

Fodor KE, Pákáski M, Santha P, Janka Z, Kálmán J.

Neuropsychopharmacol Hung. 2011 Sep;13(3):163-71. doi: 10.5706/nph201109005.

Effects of gender on burden among caregivers of Alzheimer's patients

Akpınar B, Küçükgüçlü O, Yener G.

J Nurs Scholarsh. 2011 Sep;43(3):248-54. doi: 10.1111/j.1547-5069.2011.01402.x. Epub 2011 Jul 18.

[How to manage gait and balance disorders among older adults aged 65 years and older with mild to moderate dementia in clinical practice?]

de Decker L, Annweiler C, Yvain F, Leroux P, Lermite P, Berrut G, Hily S, Beauchet O.

Geriatr Psychol Neuropsychiatr Vieil. 2011 Sep;9(3):269-76. doi: 10.1684/pnv.2011.0291.

[Dementia: progress in diagnosis and treatment; editorial, towards the preclinical treatment of Alzheimer disease]

Iwatsubo T.

Nihon Naika Gakkai Zasshi. 2011 Aug 10;100(8):2089-91. doi: 10.2169/naika.100.2089.

Oxidative stress and β-amyloid protein in Alzheimer's disease

Cai Z, Zhao B, Ratka A.

Neuromolecular Med. 2011 Dec;13(4):223-50. doi: 10.1007/s12017-011-8155-9. Epub 2011 Sep 8.

Epigenetics in Alzheimer's disease: a focus on DNA modifications

Coppieters N, Dragunow M.

Curr Pharm Des. 2011;17(31):3398-412. doi: 10.2174/138161211798072544.

Apolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer's disease

Keene CD, Cudaback E, Li X, Montine KS, Montine TJ.

Curr Opin Neurobiol. 2011 Dec;21(6):920-8. doi: 10.1016/j.conb.2011.08.002. Epub 2011 Sep 8.

[Pharmacological and clinical profiles of galantamine (Reminyl(®))]

Nagino K, Shikinami K, Saito T, Harada Y.

Nihon Yakurigaku Zasshi. 2011 Sep;138(3):122-6. doi: 10.1254/fpj.138.122.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias